Approximately 7-10% of patients develop a chronic pain syndrome after the stroke. This chronic pain condition is called central poststroke pain (CPSP).
Of all battles against cancer, when it comes to the therapeutics for pancreatic cancer, more than ever, it is too little and too late. That is why, when Dr. Wen-Hwa Lee’s team developed an antibody and proved that it can extend the life of lab mice to twice longer than its compared group, the participating scientists are excited, for they have pushed the milestone one step further in finding the therapeutics for pancreatic cancer patients
Internet is huge! Help us find great content
Never miss a thing! Sign up for our newsletter to stay updated.
Research Stash is a curated collection of tools and News for S.T.E.M researchers
Have any questions or want to partner with us? Reach us at hello@researchstash.com
